strategic alternatives
Kane Biotech Engages DNA Advisors to Explore Strategic Alternatives
Kane Biotech Inc. (TSXV: KNE), a Canadian biotechnology company focused on antimicrobial wound care products, has engaged DNA Advisors Inc. as its exclusive financial advisor to evaluate strategic alternatives for the company. According to Kane Biotech’s August 5 announcement, the review may include potential partnerships, financings, acquisitions, commercial collaborations and other strategic transactions. The company…
